secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2023-09-06T23:59:59+00:00
Accession:  0001799191-23-000044
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

The Oncology Institute appoints Jeremy Castle as COO with $375K base salary
---------------------------------------------------------------------------

- Jeremy N. Castle appointed COO effective September 5, 2023, replacing Matthew Miller, MD who departed June 16, 2023.
- Castle previously served as VP of Operations at OneOncology (Jan 2022-Aug 2023); over 15 years in healthcare operations.
- Base salary $375,000; target annual bonus 40% of base; $50,000 signing/relocation bonus.
- Employment agreement has three-year initial term; severance of three months salary/COBRA if terminated without cause or for good reason.
- No family relationships with directors/officers; no related party transactions required to be disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000044/0001799191-23-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000044/toi-20230906.htm
  HTML page:      https://secwatch.observer/filing/0001799191-23-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer